Many studies have used putative cancer stem cell markers, such as CD133, CD44, ABCG2, and side population via Hoechst efflux assay, to isolate and enrich for cells capable of forming tumors [tumor-initiating cells (TIC)] [13, 35, 66–72]. Here, ABCG2 is linked to neoplasm.